Scinovex
article Open AccessTop 1% cited

The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure

New England Journal of Medicine · 2005 · Vol. 352(15) · pp. 1539–1549
John G.F. ClelandJean‐Claude DaubertErland ErdmannNick FreemantleDaniel GrasLukas KappenbergerLuigi Tavazzi

Abstract

In patients with heart failure and cardiac dyssynchrony, cardiac resynchronization improves symptoms and the quality of life and reduces complications and the risk of death. These benefits are in addition to those afforded by standard pharmacologic therapy. The implantation of a cardiac-resynchronization device should routinely be considered in such patients.

Cardiac pacing and defibrillation studiesCardiovascular Function and Risk FactorsCardiomyopathy and Myosin StudiesMedicineCardiac resynchronization therapyHeart failureCardiologyInternal medicineHazard ratioEjection fractionVentricular dyssynchronyConfidence intervalClinical endpoint

MeSH terms

AgedCardiac Pacing, ArtificialCombined Modality TherapyFemaleFollow-Up StudiesHeart FailureHospitalizationHumansMaleMiddle AgedMyocardial ContractionPacemaker, ArtificialStroke VolumeSurvival AnalysisVentricular Dysfunction, Left
Citations
6,231
FWCI
263.14
field-weighted impact
References
36
Percentile
100%
vs. same field & year
Citations per year
Cited by
Defining Left Bundle Branch Block in the Era of Cardiac Resynchronization Therapy
The American Journal of Cardiology · 2011 · 674 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.